EUVIMEDEUVIMED entdecken
Crossref

Tigecycline: a novel broad spectrum antibiotic

Dilip Nathwani

Future Prescriber · 2006

DOI: 10.1002/fps.23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Future Prescriber, 2006. Verfasst von Dilip Nathwani.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Healthcare associated infections (HAIs) affect around 2 million people admitted to acute care hospitals in the USA. 1 Approximately 9 per cent of patients in UK hospitals suffer from an infection acquired during their hospital stay, 2 many of which are due to multi‐resistant, Gram‐positive and Gram‐negative patho‐gens. The incidence of colonisation and infection with these pathogens continues to rise due to failures in hospital hygiene, selective pressures created by overuse of antibiotics, and mobile elements that can enc‐ode bacterial resistance mechanisms. Copyright © 2006 John Wiley & Sons, Ltd.

Zitieren

APA

Nathwani, D. (2006). Tigecycline: a novel broad spectrum antibiotic. Future Prescriber. https://doi.org/10.1002/fps.23

Vancouver

Nathwani D. Tigecycline: a novel broad spectrum antibiotic. Future Prescriber. 2006. doi:10.1002/fps.23

BibTeX
@article{Nathwani2006,
  author = {Nathwani, Dilip},
  title = {Tigecycline: a novel broad spectrum antibiotic},
  journal = {Future Prescriber},
  year = {2006},
  doi = {10.1002/fps.23}
}
Kostenlos starten →